The affordable price becomes the important criterion for choosing effective medicines, Indian Ambassador to Ukraine Partha Satpathy has said.
“Today, the low price offered for an effective and high-quality drug is becoming a very important criterion for choosing medicines. Leading Indian pharmaceutical companies introduce medicines manufactured at modern production sites, taking into account the laws of countries with Stringent Regulatory Authorities, the requirements of EU regulatory agencies and the FDA, to the Ukrainian market,” he said during the third annual business seminar entitled “India – a Global Force in Pharmaceuticals, a Reliable Partner for Ukraine” organized by the Indian Pharmaceutical Manufacturers’ Association (IPMA) in cooperation with the Embassy of India in Ukraine last week in Kyiv.
The ambassador said that the government of India has determined the production of effective and affordable medicines, which the country can provide not only with the needs of the domestic market, but also with export, as one of the directions of state policy.
“The Indian pharmaceutical industry is so successful that it is capable to satisfy the needs of not only the domestic market of India, but the whole world. These needs are met on the basis of two principles: the availability of medicines and their reasonable price. Indeed, the health of many people depends on the availability of efficiency and the price of medicines,” he said.
Satpathy recalled that “the Indian government has taken certain steps: it has identified priority medicines, encouraged the manufacturing companies of these medicines and determined the basis for the implementation of the state regulatory policy to ensure the quality and effectiveness of medicines.”
The ambassador also said that Indian medicines can play a significant role in the implementation of the government’s Affordable Medicines program in Ukraine.
“It is high-quality medicines at a reasonable price that play an important role in this program. Therefore, the Indian side can be useful in this direction,” he said.
In addition, Satpathy noted the potential of Indian pharmaceutical companies in the segment of vaccines, oncology and drugs for the treatment of cardiovascular diseases for the entire world, as well as in the production of innovative medicines.
According to Proxima Research, in January-October 2019, 41.3 million packages of Indian medicines were sold on the retail market of Ukraine for a total of UAH 4.369 billion, which is 6.3% in cash and 4.6% in kind of the entire retail pharmaceutical market of Ukraine.
In turn, IPMA President Dr. Menon Ramanan Unni Parambath emphasized the willingness of leading Indian manufacturers to provide Ukrainian patients with a wide range of effective and high-quality medications at affordable prices.
For his part, Deputy Minister of Health of Ukraine Dmytro Koval said that the quality of registered Indian drugs is in line with international standards, and leading health experts acknowledge this.
According to the data announced during the seminar, the top 10 in terms of sales in the Ukrainian retail market among Indian companies in January-October 2019included, in particular, Dr. Reddy’s Laboratories Ltd. (UAH 632.078 million or 5.392 million packages), Organosyn Life Sciences (UAH 460.279 million), Abryl Formulations (UAH 268.204 million), Sun Pharma (UAH 216.326 million), Euro Lifecare (UAH 188.365 million) and Macleods Pharmaceuticals (UAH 157.947 million). They are members of IPMA.
Ambassador of the European Union (EU) to Ukraine Matti Maasikas is satisfied with the pace of improvement of the business climate in the country.
The new government and the new president have taken an obligation to improve business climate, he said at the Kyiv International Economic Forum on Friday, adding that there is significant progress in the legislative process seen in the parliament if to speak about the improvement of business environment and fight against corruption.
Maasikas called the achievement of the rule of law, the fight against corruption among the main problems that Ukraine should solve. At the same time, he said that he sees positive trends in this direction.
The dynamics are positive if we talk about the law on illegal enrichment, the ambassador said. In addition, there are other examples – the fight against money laundering, he added.
President of Ukraine Volodymyr Zelensky may appoint Ambassador of Ukraine to the UN Volodymyr Yelchenko as the ambassador of Ukraine to the United States of America, the Ukrainian Voice of America service reports.
“At this post [Ukrainian Permanent Representative to the UN], an experienced diplomat Yelchenko repeatedly resolutely maintained Ukraine’s position, often in fierce exchanges of remarks with the Russian delegation during the organization’s meetings,” it said.
Zelensky said during a press marathon on October 10 that he had decided on the candidacy of the ambassador to the United States, but did not say who he had chosen.
“A person has been chosen, this is experienced person, a diplomat, who knows the United States very well. I think he will be appointed in the near future,” Zelensky said then.
Earlier, Valeriy Chaly held the post of ambassador.
AMBASSADOR, U.S.А, UKRAINE, UN
U.S. President Trump ordered the removal of the ambassador to Ukraine after months of complaints from allies outside the administration, including his personal lawyer Rudy Giuliani, that she was undermining him abroad and obstructing efforts to persuade Kyiv to investigate former Vice President Joe Biden, the Wall Street Journal has reported.
Trump’s personal lawyer Giuliani told the newspaper that Yovanovitch was biased against the U.S. president in private conversations and prevented Ukraine from conducting an investigation into Biden and his son Hunter.
In addition, the newspaper reports that Giuliani handed over to the U.S. Secretary of State Mike Pompeo a nine-page document dated March 28 containing a schedule of Biden’s business meetings in Ukraine.
The document also claimed that Yovanovitch was very close to the former vice president.
It is noted that although the U.S. Department of State presented Yovanovitch’s departure from Ukraine in May as planned, her tenure as ambassador was three months shorter than the usual three-year term.
Earlier, U.S. media reported that Trump tried in a telephone conversation on July 25 to convince Zelensky of the need to launch an investigation against Hunter Biden, the son of former Vice President Joe Biden.
An American intelligence officer complained in writing, and members of the U.S. Congress received the complaint for review. The complaint of intelligence officer statement prompted Democrats in the House of Representatives to initiate impeachment hearings against Trump.
In addition to U.S. Special Representative for Ukraine Negotiations Kurt Volker and former U.S. Ambassador to Ukraine Yovanovitch, democrats also requested State Department Deputy Assistant Secretary George Kent, State Department counselor T. Ulrich Brechbuhl and U.S. Ambassador to the European Union Gordon Sondland appear for depositions at the Congress.
On Thursday, Trump explicitly called on Ukraine and China to launch investigations into the activities of former U.S. Vice President Joe Biden and his companies.
The new Ambassador of France to Ukraine, Etienne de Poncins, has arrived in Kyiv. “I’ve safely arrived in Kyiv. My mission as the head of the French Embassy in Ukraine may begin,” the diplomat wrote on Twitter.
Etienne de Poncins was appointed Ambassador of France to Ukraine on July 24. Prior to that, he worked as an inspector of the French Foreign Ministry, and in the European External Action Service, and was also the French ambassador to Kenya and Bulgaria.
The previous Ambassador of France to Ukraine, Isabelle Dumont, completed her work in Ukraine on July 27.
The Embassy of India in Kyiv in cooperation with the Pharmaceuticals Export Promotion Council of India (Pharmexcil) and the Indian Pharmaceutical Manufacturers Association (IPMA) will hold an annual business seminar in Ukraine to promote and demonstrate the potential of India in the pharmaceutical manufacturing sectors, Indian Ambassador to Ukraine Partha Satpathy has stated at a press conference at Interfax-Ukraine. “Pharmexcil is the Pharmaceuticals Export Promotion Council of India. The main task of this organization is to unite all important pharmaceutical manufacturers in India. The council cooperates with the government, represents the interests of manufacturers in exports, in particular brings pharmaceutical products in compliance with the requirements of the WHO and the importing country,” the ambassador said.
President of the Indian Pharmaceutical Manufacturers Association (IPMA) Dr. Menon, in turn, said that Pharmexcil plans to present several projects in Ukraine.
“Pharmexcil wants to find partners in Ukraine in the field of Ayurveda, clinical trials and create a joint venture for production of medicines,” he said.
The Indian ambassador noted that India is the third largest exporter of pharmaceutical products to Ukraine following Germany and France in terms of value, while Indian pharmaceutical companies supply high-quality products at a very good and competitive price.
